Yahoo! Finance: Biotechnology Industry News: Repros Receives FDA Guidance For Androxal(R) Clinical Program

Yahoo! Finance: Biotechnology Industry News The latest news on the Biotechnology industry from Yahoo! Finance

TypePad Has the Tools Looking for a premiere blogging service? Start your blog today on TypePad. From our sponsors

Repros Receives FDA Guidance For Androxal(R) Clinical Program Oct 23rd 2013, 00:00 [GlobeNewswire] - THE WOODLANDS, Texas -- Repros Therapeutics Inc.(R) today reported it has received guidance from the FDA regarding its clinical program for Androxal.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions